Dong-mee Lim
Daejeon, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Ruptured triple hormone-secreting adrenal cortical carcinoma with hyperaldosteronism, hypercortisolism, and elevated normetanephrine: a case report.
Journal: Journal of Yeungnam medical science
Published: June 20, 2024
Response: Effects of 6 Months of Dapagliflozin Treatment on Metabolic Profile and Endothelial Cell Dysfunction for Obese Type 2 Diabetes Mellitus Patients without Atherosclerotic Cardiovascular Disease (J Obes Metab Syndr 2020;29:215-21).
Journal: Journal of obesity & metabolic syndrome
Published: January 25, 2021
Serum Transferrin Predicts New-Onset Type 2 Diabetes in Koreans: A 4-Year Retrospective Longitudinal Study.
Journal: Endocrinology and metabolism (Seoul, Korea)
Published: May 26, 2020
Effects of 6 Months of Dapagliflozin Treatment on Metabolic Profile and Endothelial Cell Dysfunction for Obese Type 2 Diabetes Mellitus Patients without Atherosclerotic Cardiovascular Disease.
Journal: Journal of obesity & metabolic syndrome
Published: April 30, 2020
Difference in protective effects of GIP and GLP-1 on endothelial cells according to cyclic adenosine monophosphate response.
Journal: Experimental and therapeutic medicine
Published: November 05, 2015
Serum vitamin d status and its relationship to metabolic parameters in patients with type 2 diabetes mellitus.
Journal: Chonnam medical journal
Published: June 07, 2012
Exendin-4 increases bone mineral density in type 2 diabetic OLETF rats potentially through the down-regulation of SOST/sclerostin in osteocytes.
Journal: Life sciences
Published: June 05, 2012
Exendin-4 protects against sulfonylurea-induced β-cell apoptosis.
Journal: Journal of pharmacological sciences
Published: December 22, 2011
Showing 1-8 of 8
Last Updated: 09/26/2026